|
|
Sanofi Ventures is the corporate venture capital arm of Sanofi. Previously known as Sanofi-Genzyme BioVentures, the firm offers its portfolio companies access to Sanofi's established expertise and capabilities in science, preclinical and clinical development, regulatory, manufacturing, market access, commercialization, and more. Sanofi invests in early-stage companies developing transformative technologies and products that are considered too early for business development. Sanofi Ventures invests directly in private early-stage biotech and digital health companies with transformative new products and technologies that align with Sanofi's strategy. Current core areas of strategic interest include: rare diseases; vaccines; breakthrough therapies in other core areas of interest: immunology, neurology, oncology, diabetes, and cardiovascular disease; and digital health.
|
